{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:08:05Z","timestamp":1759104485830},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12903-015-0023-9","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T16:14:20Z","timestamp":1426781660000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Chaminda Jayampath","family":"Seneviratne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phoenix HL","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah SW","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor HF","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"23_CR1","doi-asserted-by":"crossref","unstructured":"Sullivan DJ, Moran GP, and Coleman DC. 2011. Fungal Infections of Humans. P. 257-278. Fungi: Biology and Applications. 2nd ed. Edited by Kavanagh K. John Wilet & Sons, Ltd.","DOI":"10.1002\/9781119976950.ch10"},{"issue":"Suppl 8","key":"23_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00520-010-0892-z","volume":"18","author":"RV Lalla","year":"2010","unstructured":"Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D\u2019Amato-Palumbo S, Fischer DJ, et al. A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer. 2010;18 Suppl 8:985\u201392.","journal-title":"Support Care Cancer."},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1044579X02000858","volume":"12","author":"MC Yu","year":"2002","unstructured":"Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421\u20139.","journal-title":"Semin Cancer Biol."},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1200\/JCO.2008.19.9109","volume":"27","author":"N Lee","year":"2009","unstructured":"Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27:3684\u201390.","journal-title":"J Clin Oncol."},{"issue":"Suppl 4","key":"23_CR5","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.ijrobp.2006.06.013","volume":"66","author":"EHN Pow","year":"2006","unstructured":"Pow EHN, Kwong DLW, McMillan AS, Wong MCM, Sham JST, Leung LHT, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006;66 Suppl 4:981\u201391.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"23_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1472-6831-12-22","volume":"12","author":"M Panghal","year":"2012","unstructured":"Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC Oral Health. 2012;12:12.","journal-title":"BMC Oral Health."},{"issue":"Suppl 1","key":"23_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1067\/moe.2002.126018","volume":"94","author":"JB Epstein","year":"2002","unstructured":"Epstein JB, Tsang AH, Warkentin D, Ship JA. The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94 Suppl 1:39\u201344.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod."},{"issue":"Suppl 1","key":"23_CR8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/714030907","volume":"38","author":"GS Hoog De","year":"2000","unstructured":"De Hoog GS, Queiroz-Telles F, Haase G, Fernandez-Zeppenfeldt G, Attili Angelis D, Gerrits Van Den Ende AH, et al. Black fungi: clinical and pathogenic approaches. Med Mycol. 2000;38 Suppl 1:243\u201350.","journal-title":"Med Mycol."},{"issue":"Suppl 3","key":"23_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3314\/jjmm.37.135","volume":"37","author":"RY Li","year":"1996","unstructured":"Li RY, Wang DL. Studies on phaeohyphomycosis and its causative agents in China. Japan J Med Mycol. 1996;37 Suppl 3:135\u201341.","journal-title":"Japan J Med Mycol."},{"issue":"Suppl 2","key":"23_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mimet.2009.11.007","volume":"80","author":"M Sudhadham","year":"2010","unstructured":"Sudhadham M, de Hoog GS, Menken SBJ, van den Ende AHG, Sihanonth P. Rapid screening for genotypes as possible markers of virulence in the neurotropic black yeast Exophiala dermatitidis using PCR-RFLP. J Microbiol Methods. 2010;80 Suppl 2:138\u201342.","journal-title":"J Microbiol Methods."},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1439-0507.2002.00779.x","volume":"45","author":"T Matos","year":"2002","unstructured":"Matos T, de Hoog GS, de Boer AG, de Crom I, Haase G. High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses. 2002;45:373\u20137.","journal-title":"Mycoses."},{"issue":"Suppl 4","key":"23_CR12","doi-asserted-by":"publisher","first-page":"e136","DOI":"10.1111\/j.1439-0507.2010.01859.x","volume":"54","author":"DM Li","year":"2011","unstructured":"Li DM, Li RY, de Hoog GS, Sudhadham M, Wang DL. Fatal Exophiala infections in China, with a report of seven cases. Mycoses. 2011;54 Suppl 4:e136\u201342.","journal-title":"Mycoses."},{"key":"23_CR13","volume-title":"Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline. Document M44-A","author":"Clinical and Laboratory Standards Institute\/National Committee for Clinical Laboratory Standards","year":"2004","unstructured":"Clinical and Laboratory Standards Institute\/National Committee for Clinical Laboratory Standards. Method for antifungal disk diffusion susceptibility testing of yeasts: approved guideline. Document M44-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2004."},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1128\/JCM.01900-06","volume":"45","author":"A Espinel-Ingroff","year":"2007","unstructured":"Espinel-Ingroff A, Canton E, Gibbs D, Wang A. Correlation of Neo-Sensitabs tablet diffusion assay results on three different agar media with CLSI broth microdilution M27-A2 and disk diffusion M44-A results for testing susceptibilities of Candida spp. and Cryptococcus neoformans to amphotericin B, caspofungin, fluconazole, itraconazole, and voriconazole. J Clin Microbiol. 2007;45:858\u201364.","journal-title":"J Clin Microbiol"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1128\/AAC.00541-08","volume":"52","author":"CJ Seneviratne","year":"2008","unstructured":"Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP. Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother. 2008;52:3259\u201366.","journal-title":"Antimicrob Agents Chemother."},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1128\/JCM.41.7.2961-2967.2003","volume":"41","author":"Y Jin","year":"2003","unstructured":"Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol. 2003;41:2961\u20137.","journal-title":"J Clin Microbiol."},{"key":"23_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.archoralbio.2004.04.011","volume":"49","author":"Y Jin","year":"2004","unstructured":"Jin Y, Samaranayake LP, Samaranayake Y, Yip HK. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol. 2004;49:789\u201398.","journal-title":"Arch Oral Biol."},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1128\/JCM.39.8.2971-2974.2001","volume":"39","author":"G Luo","year":"2001","unstructured":"Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001;39:2971\u20134.","journal-title":"J Clin Microbiol."},{"key":"23_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1099\/00222615-44-4-311","volume":"44","author":"T Wu","year":"1996","unstructured":"Wu T, Samaranayake LP, Cao BY, Wang J. In vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol. 1996;44:311\u20136.","journal-title":"J Med Microbiol."},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1128\/JCM.02336-12","volume":"51","author":"PC Woo","year":"2013","unstructured":"Woo PC, Ngan AH, Tsang CC, Ling IW, Chan JF, Leung SY, et al. Clinical spectrum of Exophiala infections and a novel Exophiala species, Exophiala hongkongensis. J Clin Microbiol. 2013;51:260\u20137.","journal-title":"J Clin Microbiol."},{"issue":"Suppl 1","key":"23_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","volume":"49","author":"D Ellis","year":"2002","unstructured":"Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49 Suppl 1:7\u201310.","journal-title":"J Antimicrob Chemother."},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1046\/j.1439-0507.2003.00956.x","volume":"47","author":"AS Kantarcioglu","year":"2004","unstructured":"Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: a review of cases presented between 1999 and 2004. Mycoses. 2004;47:4\u201313.","journal-title":"Mycoses."},{"issue":"Suppl 3","key":"23_CR23","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/myc.12009","volume":"56","author":"AK Patel","year":"2013","unstructured":"Patel AK, Patel KK, Darji P, Singh R, Shivaprakash MR, Chakrabarti A. Exophiala dermatitidis endocarditis on native aortic valve in a postrenal transplant patient and review of literature on E. dermatitidis infections. Mycoses. 2013;56 Suppl 3:365\u201372.","journal-title":"Mycoses"},{"key":"23_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11046-012-9597-9","volume":"175","author":"AP Duarte","year":"2013","unstructured":"Duarte AP, Pagnocca FC, Baron NC, Melhem Mde S, Palmeira GA, de Angelis DF, et al. In vitro susceptibility of environmental isolates of Exophiala dermatitidis to five antifungal drugs. Mycopathologia. 2013;175:455\u201361.","journal-title":"Mycopathologia."}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12903-015-0023-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-015-0023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-015-0023-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-015-0023-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T04:48:05Z","timestamp":1566449285000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-015-0023-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1186\/s12903-015-0023-9","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]},"assertion":[{"value":"6 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"39"}}